These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 12193750)

  • 1. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
    Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of a CD4
    Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
    Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
    Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
    Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
    Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
    J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early events in peripheral regulatory T cell induction via the nasal mucosa.
    Unger WW; Hauet-Broere F; Jansen W; van Berkel LA; Kraal G; Samsom JN
    J Immunol; 2003 Nov; 171(9):4592-603. PubMed ID: 14568933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
    Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
    J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells.
    Kitani A; Chua K; Nakamura K; Strober W
    J Immunol; 2000 Jul; 165(2):691-702. PubMed ID: 10878341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
    Vahlenkamp TW; Tompkins MB; Tompkins WA
    J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25-expressing Th17 cells mediate CD8
    Lang C; Wang J; Chen L
    Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population.
    Jump RL; Levine AD
    J Immunol; 2002 Jun; 168(12):6113-9. PubMed ID: 12055222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
    Masuyama J; Kaga S; Kano S; Minota S
    J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.